• Return to Headlines

FDA Advisory Panel Approves Medtronic Brain Stimulation Implant (MDT)

Written on Sat, 03/13/2010 - 11:12am
By Chip Brian

3/13/2010-Shares of Medtronic (NYSE:MDT) rose 1.25% to $44.49 after hours on Friday after Federal health advisers said the company's brain stimulating device can be approved for epilespy, provided the company conducts follow-up safety studies.
The Food and Drug Administration's panel of neurological experts voted 7-5 in favor of Medtronic's Deep Brain Stimulation implant.
The experts said it should carry warning about depression and memory loss and that Medtronic should track patient safety for five years.
The FDA is not required to follow the panel's advice, though it often does.

Keywords: Medtronic fda panel approval brain implant epilepsy Stock smartrend

Ticker(s): MDT

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.